Ziyuglycoside II ameliorates chemotherapy-induced neutropenia by promoting neutrophil differentiation and functional recovery via SPI1 and C/EBPϵ transcriptional regulation

BackgroundChemotherapy-induced neutropenia (CIN) remains a major dose-limiting toxicity associated with myelosuppressive chemotherapy regimens. The development of therapeutic strategies capable of effectively restoring neutrophil production and function could address a critical unmet clinical issue....

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Lingdi Li, Huan Lei, Luqi Chen, Chunye Cao, Haolin He, Yanfeng Zhang, Lin Zhang, Liang Peng, Yuxiu Yang, Yulin Feng, Haihong Fang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2026-02-01
Saila:	Frontiers in Immunology
Gaiak:	C/EBPϵ chemotherapy-induced neutropenia neutrophil differentiation SPI1 transcriptional regulation Ziyuglycoside II
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1771161/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!